121 related articles for article (PubMed ID: 11816485)
1. [Antimetastatic and antitumor effects of fluoropyrimidines alone and combined with taxanes in a murine model of breast cancer metastatic to the lung].
Nukatsuka M; Fujioka A; Nakagawa F; Ohshimo H; Fukushima M
Gan To Kagaku Ryoho; 2002 Jan; 29(1):95-101. PubMed ID: 11816485
[TBL] [Abstract][Full Text] [Related]
2. Antimetastatic and anticancer activity of S-1, a new oral dihydropyrimidine-dehydrogenase-inhibiting fluoropyrimidine, alone and in combination with paclitaxel in an orthotopically implanted human breast cancer model.
Nukatsuka M; Fujioka A; Nakagawa F; Oshimo H; Kitazato K; Uchida J; Sugimoto Y; Nagayama S; Fukushima M
Int J Oncol; 2004 Dec; 25(6):1531-6. PubMed ID: 15547687
[TBL] [Abstract][Full Text] [Related]
3. [The antitumor activity of DPD inhibitory-fluoropyrimidine (DIF) and non-DIF alone or in combination with paclitaxel against orthotopically implanted human breast cancer].
Nukatsuka M; Fujioka A; Nakagawa F; Ohshimo H; Kitazato K; Fukushima M
Gan To Kagaku Ryoho; 2002 May; 29(5):803-6. PubMed ID: 12040690
[No Abstract] [Full Text] [Related]
4. [Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats].
Ogata Y; Akagi Y; Nozoe Y; Sasatomi T; Miyagi Y; Nakagawa M; Matono K; Kobayashi H; Shirouzu K
Gan To Kagaku Ryoho; 2001 May; 28(5):655-60. PubMed ID: 11383214
[TBL] [Abstract][Full Text] [Related]
5. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
Fukushima M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
[TBL] [Abstract][Full Text] [Related]
6. Correlations between antitumor activities of fluoropyrimidines and DPD activity in lung tumor xenografts.
Takechi T; Okabe H; Ikeda K; Fujioka A; Nakagawa F; Ohshimo H; Kitazato K; Fukushima M
Oncol Rep; 2005 Jul; 14(1):33-9. PubMed ID: 15944764
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase.
Nio Y; Iguchi C; Kodama H; Itakura M; Hashimoto K; Koike M; Toga T; Maruyama R; Fukushima M
Oncol Rep; 2007 Jan; 17(1):153-9. PubMed ID: 17143493
[TBL] [Abstract][Full Text] [Related]
8. [Antiproliferative and antimetastatic effects of UFT on MKL-4 human breast cancer cells transplanted into nude mice].
Kurebayashi J; Sonoo H
Gan To Kagaku Ryoho; 1995 Apr; 22(5):665-70. PubMed ID: 7717719
[TBL] [Abstract][Full Text] [Related]
9. [Antitumor activity of UFT and docetaxel on human breast carcinoma xenografts].
Yamada T; Yamada Y; Asanuma F; Kawamura E; Suzuki T
Gan To Kagaku Ryoho; 2000 Oct; 27(11):1725-30. PubMed ID: 11057324
[TBL] [Abstract][Full Text] [Related]
10. Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy.
Munoz R; Man S; Shaked Y; Lee CR; Wong J; Francia G; Kerbel RS
Cancer Res; 2006 Apr; 66(7):3386-91. PubMed ID: 16585158
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of combination of S-1 and docetaxel on the human breast cancer xenograft transplanted into SCID mice.
Suto A; Kubota T; Fukushima M; Ikeda T; Takeshita T; Ohmiya H; Kitajima M
Oncol Rep; 2006 Jun; 15(6):1517-22. PubMed ID: 16685389
[TBL] [Abstract][Full Text] [Related]
12. Life prolonging effect of antitumor agents on postoperative adjuvant therapy in the lung spontaneous metastasis model in mice.
Shibata J; Murakami K; Abe M; Hashimoto A; Utsugi T; Fukushima M; Yamada Y
Anticancer Res; 1998; 18(2A):1203-9. PubMed ID: 9615789
[TBL] [Abstract][Full Text] [Related]
13. The role of UFT and the combination of UFT/leucovorin in non-small cell lung cancer.
Langer CJ
Lung Cancer; 2001 Nov; 34(2):297-303. PubMed ID: 11679189
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor activity and toxicity to the immune system and intestine, of the fluorinated pyrimidines FUra, 5'-DFUR, tegafur and UFT].
Ninomiya Y; Ryu M; Matsuura N; Fujimoto K; Miwa M; Ishitsuka H
Gan To Kagaku Ryoho; 1988 May; 15(5):1747-54. PubMed ID: 2967050
[TBL] [Abstract][Full Text] [Related]
15. Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts.
Nukatsuka M; Saito H; Nakagawa F; Abe M; Uchida J; Shibata J; Matsuo K; Noguchi S; Kiniwa M
Breast Cancer Res Treat; 2011 Jul; 128(2):381-90. PubMed ID: 20809360
[TBL] [Abstract][Full Text] [Related]
16. [A case of recurrent breast cancer with lung metastasis and overexpression of HER2 that responded to UFT and cyclophosphamide combination therapy after sequential treatments with epirubicin, taxanes, and trastuzumab].
Nishimura R; Nagao K; Miyayama H; Okazaki S; Nakagawa K; Fujimura Y
Gan To Kagaku Ryoho; 2003 Jun; 30(6):879-82. PubMed ID: 12852361
[TBL] [Abstract][Full Text] [Related]
17. Antitumor efficacy of combination chemotherapy with UFT and cyclophosphamide against human breast cancer xenografts in nude mice.
Haga S; Shimizu T; Imamura H; Watanabe O; Kinoshita J; Fukushima M; Kajiwara T
Anticancer Res; 1999; 19(3A):1791-6. PubMed ID: 10470117
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between antitumor activity and the inhibition of thymidylate synthase after oral administration of UFT in nude mice bearing human tumor].
Fujita M; Fujita F; Uchida J; Takeda S; Yamada Y; Taguchi T
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):627-32. PubMed ID: 2108611
[TBL] [Abstract][Full Text] [Related]
19. Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.
Sakurai Y; Yoshida I; Kamoshida S; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
Ann Surg Oncol; 2008 Aug; 15(8):2301-9. PubMed ID: 18506536
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats.
Shirasaka T; Nakano K; Takechi T; Satake H; Uchida J; Fujioka A; Saito H; Okabe H; Oyama K; Takeda S; Unemi N; Fukushima M
Cancer Res; 1996 Jun; 56(11):2602-6. PubMed ID: 8653704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
